Your browser doesn't support javascript.
loading
Buccal mucosal delivery of a potent peptide leads to therapeutically-relevant plasma concentrations for the treatment of autoimmune diseases.
Jin, Liang; Boyd, Ben J; White, Paul J; Pennington, Michael W; Norton, Raymond S; Nicolazzo, Joseph A.
Affiliation
  • Jin L; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
  • Boyd BJ; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
  • White PJ; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
  • Pennington MW; Peptides International, Louisville, KY, USA.
  • Norton RS; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
  • Nicolazzo JA; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia. Electronic address: joseph.nicolazzo@monash.edu.
J Control Release ; 199: 37-44, 2015 Feb 10.
Article in En | MEDLINE | ID: mdl-25482338
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Peptides / Autoimmune Diseases / Drug Delivery Systems / Cnidarian Venoms / Administration, Mucosal / Immunologic Factors / Mouth Mucosa Type of study: Prognostic_studies Limits: Animals Language: En Year: 2015 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Peptides / Autoimmune Diseases / Drug Delivery Systems / Cnidarian Venoms / Administration, Mucosal / Immunologic Factors / Mouth Mucosa Type of study: Prognostic_studies Limits: Animals Language: En Year: 2015 Type: Article